A more recent and much larger multicenter, population-based study published yesterday in JAMA Ophthalmology has revealed an elevated inherent relative risk (incidence rate ratio, 1.32) of NAION for those exposed to semaglutide thats much smaller than the 4.28-fold hazard ratio (HR) found in a study published last summer.1 This was a retrospective study across 14 databases (six administrative claims and eight electronic health records)
Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications
Global burden of NAFLD and chronic liver disease among adolescents and young adults
Take your medication at regular intervals
Main ingredients: Glutathione: It is involved in tissue building and repair, making chemicals and proteins needed in the body, and in immune system function